Bhaswat Chakraborty

Biography

Dr. Bhaswat S Chakraborty is currently 2005 to 2010 a Senior VP Research Development of Cadila Pharmaceuticals Ltd, Ahmedabad, Gujarat, India where he is responsible for Clinical Pharmacology Clinical Trials Ph IIV. Bioequivalence Trials Preclinical Studies Bioinformatics and Data Management. He is also an Adjunct Faculty of Albany College of Pharmacy and Health Sciences Albany New York USA; Editorial Board Member Journal of Bioequivalence Bioavailability; PhD Guide and External Examiner to a number of Universities in India. He has been a reviewer for several international journals and member of Ethics Committee and DSMB Dr Chakraborty received his PhD 1987 in Clinical Pharmacology from University of Sakatchewan, Canada. He served as a Senior Safety and Efficacy Reviewer 1989 to 1997 and Acting Division Chief at the Therapeutic Drugs Directorate Canadian FDA, Ottawa, Canada. Dr. Chakraborty also served as the Director of Biopharmaceutics 1997 to 2000 Biovail Contract Research Toronto, Canada and President of Foresee Consultant until the present assignmentHe is founder of a Spiritual Association. Dr. Chakraborty has more than 60 research papers and abstracts in peer reviewed journals. He has received many merit awards and AAPS Visiting Scientist Awards.

Research Interest

Mind-Body Medicine and Positive Mental Culture  Randomized Clinical Trials of Anticancer Drugs and Vaccines  Randomized Clinical Trials of Cardiovascular and Antidiabetic Drugs  Animal and Human Ethics  Operational Research in Clinical Trials Management  Analysis and Interpretation of Clinical Trial Data  Analysis of Biological Samples using LC-MS-MS with a special focus on Elimination or Estimation of Matrix Effects  Toxic Signal Detection by Data Mining in Pharmacovigilance.